Anzeige
Mehr »
Login
Donnerstag, 25.02.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Adhoc-Meldung: Eine ganz große Überraschung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6SG ISIN: US8693671021 Ticker-Symbol: S09 
Frankfurt
25.02.21
09:16 Uhr
18,600 Euro
+1,000
+5,68 %
1-Jahres-Chart
SUTRO BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
SUTRO BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
18,50019,10012:24
8,4509,80031.03.20

Aktuelle News zur SUTRO BIOPHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.01.Sutro: Leading Cell Free Protein Synthesis Company With Promising Early Data5
09.12.20Sutro Biopharma prices $126M public offering5
09.12.20Sutro Biopharma (STRO) Investor Presentation - Slideshow1
SUTRO BIOPHARMA Aktie jetzt für 0€ handeln
08.12.20Why iBio, Sutro And Cantel Medical Are Moving Today16
08.12.20Sutro Biopharma -4.6% after filing to offer 5M shares2
07.12.20SUTRO BIOPHARMA, INC. - 8-K, Current Report2
07.12.20Sutro Biopharma down after STRO-001 data in blood cancer study1
05.12.20Why Sutro Biopharma Blasted 33% Higher on Friday6
04.12.20Mid-Afternoon Market Update: Dow Surges 200 Points; Sutro Biopharma Shares Spike Higher2
04.12.20Sutro Biopharma: 7 Things for STRO Stock Investors to Know About the Biotech Company3
04.12.20Sutro Biopharma, Merrimack Pharmaceuticals leads healthcare gainers; Precision BioSciences, Cortexyme among major losers16
04.12.20Sutro's antibody-drug conjugate impresses in hard-to-treat ovarian cancer5
04.12.20The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs6
04.12.20Sutro's continued PhI data readouts indicate improving response in ovarian cancer. What's next?3
04.12.20FDA Nod For BCRX - Decision In Japan, Europe Next, ENLV Soars On COVID Trial Data, Sutro Biopharma Abuzz1.150NEW BRUNSWICK (dpa-AFX) - Today's Daily Dose brings you news about Johnson & Johnson submitting the first-ever drug for a mutation-specific lung cancer to the FDA, Sutro Biopharma's encouraging...
► Artikel lesen
04.12.20Sutro +23.5% as ovarian cancer drug study offers encouraging interim data4
03.12.20Why Sutro, Lumos And More Health Care Stocks Are Moving Today1
01.12.20SUTRO BIOPHARMA, INC. - 8-K, Current Report-
05.11.20SUTRO BIOPHARMA, INC. - 8-K, Current Report1
05.11.20SUTRO BIOPHARMA, INC. - 10-Q, Quaterly Report1
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1